Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ingevity (NGVT) Cash & Equivalents (2016 - 2025)

Ingevity (NGVT) has disclosed Cash & Equivalents for 11 consecutive years, with $78.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Equivalents rose 14.85% to $78.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $78.1 million, a 14.85% increase, with the full-year FY2025 number at $78.1 million, up 14.85% from a year prior.
  • Cash & Equivalents was $78.1 million for Q4 2025 at Ingevity, down from $83.4 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $275.4 million in Q4 2021 to a low of $68.0 million in Q2 2023.
  • A 5-year average of $127.7 million and a median of $86.5 million in 2023 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: tumbled 73.16% in 2022, then soared 60.36% in 2024.
  • Ingevity's Cash & Equivalents stood at $275.4 million in 2021, then crashed by 72.15% to $76.7 million in 2022, then increased by 25.03% to $95.9 million in 2023, then decreased by 29.09% to $68.0 million in 2024, then increased by 14.85% to $78.1 million in 2025.
  • Per Business Quant, the three most recent readings for NGVT's Cash & Equivalents are $78.1 million (Q4 2025), $83.4 million (Q3 2025), and $76.9 million (Q2 2025).